martes, 30 de octubre de 2018

Developing cancer immunotherapies - STAT

Developing cancer immunotherapies - STAT

Cancer Briefing

SPONSOR CONTENT BY BIO-RAD

Get to market faster with personalized immuno-oncology workflows

The development of a successful immunotherapy is a result of complex and challenging research. Tools need to be precise, sensitive, and they must work together seamlessly. Explore a range of integrated solutions for gene expression, protein quantitation, and cell analysis that provide the data to move your research forward.

No hay comentarios: